Breaking News Instant updates and real-time market news.

XRAY

Dentsply Sirona

$59.44

0.2 (0.34%)

, HSIC

Henry Schein

$175.92

-1.65 (-0.93%)

08:51
09/13/17
09/13
08:51
09/13/17
08:51

Online trend continues as risk in dental consumables, says Stifel

Stifel analyst Jonathan Block said his survey of 106 dental practices showed that online vendors are gaining traction, and this trend is expected to continue. 39% of respondents currently use an online vendor such as Amazon (AMZN) for 21% of their dental consumables and traction among current users is expected to climb higher while additional practices plan to start using an online vendor, noted Block, who views this trend as a long-term headwind for Patterson Companies (PDCO) and Henry Schein (HSIC). In the Dental space, he keeps a Buy rating on Dentsply Sirona (XRAY), a Hold on Henry Schein, and a Sell on Patterson.

XRAY

Dentsply Sirona

$59.44

0.2 (0.34%)

HSIC

Henry Schein

$175.92

-1.65 (-0.93%)

PDCO

Patterson Companies

$40.65

0.41 (1.02%)

AMZN

Amazon.com

$982.58

4.62 (0.47%)

  • 18

    Sep

  • 27

    Sep

XRAY Dentsply Sirona
$59.44

0.2 (0.34%)

07/13/17
FBCO
07/13/17
NO CHANGE
Target $75
FBCO
Outperform
Dentsply Sirona price target raised to $75 from $67 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Dentsply Sirona to $75 from $67 as the company adjusts its third-party distribution strategy in North America and continues to find opportunities to deploy its cash flow in an accretive fashion. The analyst reiterates an Outperform rating on the shares.
08/25/17
UBSW
08/25/17
UPGRADE
Target $40
UBSW
Neutral
Patterson Companies upgraded to Neutral from Sell at UBS
UBS analyst Michael Cherny upgraded Patterson Companies (PDCO) to Neutral from Sell, stating that his sell thesis played out more quickly than he anticipated. His call was the risk to out-year estimates as the company worked to transition away from its exclusive Sirona (XRAY) relationship in the U.S. Although he still has concerns over the growth rebound, he feels the risk/reward is more balanced. Cherny has a $40 price target on Patterson Companies shares.
08/01/17
NRCS
08/01/17
NO CHANGE
Target $76
NRCS
Buy
Dentsply Sirona estimaters reduced at Northcoast
Northcoast analyst Ed Snyder's checks indicate Patterson Companies (PDCO) sales of high technology dental equipment is weaker than expected caused by industry competition. Snyder said it appears Patterson's CEREC sales growth is down about 40-50%, despite promotional activity. As a result, he reduced Dentsply Sirona's (XRAY) second half internal growth estimate to 1.4% from 2.3% and earnings FY17 earnings estimate to $2.80 from $2.82. Snyder retains a Buy rating on Dentsply and a $76 price target.
07/26/17
GSCO
07/26/17
NO CHANGE
GSCO
Dental survey indicates Q2 upside for Align, Henry Schein, says Goldman Sachs
Goldman analyst Robert Jones said checks indicate Q2 Dental trends remained stable and point to consistent low-single-digit growth end-markets. The analyst likes Align Technology (ALGN) saying Q2 case guidance appears beatable and expects high 20% case growth driven by investments, sees Q2 upside for Henry Schein (HSIC) due to share gains from Patterson Companies (PDCO), and said Dentsply Sirona (XRAY) promotions to drive cross-selling have yet to gain traction and 2017 guidance may be aggressive, but expectations are low into the quarter.
HSIC Henry Schein
$175.92

-1.65 (-0.93%)

08/07/17
NRCS
08/07/17
UPGRADE
NRCS
Buy
Henry Schein upgraded to Buy from Neutral at Northcoast
08/17/17
CHLM
08/17/17
NO CHANGE
Target $41
CHLM
Hold
Patterson Companies price target lowered to $41 from $46 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich lowered his price target for Patterson Companies(PDCO) to $41 from $46 to reflect the soft dental consumable environment and potential market share losses once Henry Schein (HSIC) starts to sell CEREC on September 1. Given the lower valuation and good, stable end markets, the analyst thinks Patterson Companies could be an "interesting target" for a financial buyer as cash flow should start to improve over the next few quarters once the company completes the ERP implementation. He reiterates a Hold rating on Patterson Companies' shares.
08/29/17
UBSW
08/29/17
NO CHANGE
Target $204
UBSW
Buy
Henry Schein remains attractive following acquisition, says UBS
UBS analyst Michael Cherny noted Henry Schein announced it would acquire Merritt Veterinary Supplies, which he said remains consistent with the company's core growth strategy of supplementing organic growth with complementary tuck-in M&A. Cherny continues to see Henry Schein shares as attractive and reiterated his Buy rating and $204 price target.
PDCO Patterson Companies
$40.65

0.41 (1.02%)

08/22/17
CLVD
08/22/17
NO CHANGE
CLVD
Neutral
Patterson Companies fundamentals remain soft, says Cleveland Research
Cleveland Research analyst Rob Eich said Patterson Companies fundamentals remain soft due to salesforce execution and morale, management attrition and turnover, CEREC end-user sales seem to gotten incrementally worse, and execution appears to have been negatively impacted by CEREC distribution change and SAP implementation. The analyst sees risk to FY18 consensus estimates and maintains a Neutral rating.
AMZN Amazon.com
$982.58

4.62 (0.47%)

09/08/17
BMOC
09/08/17
NO CHANGE
BMOC
Fast food restaurants more insulated from Amazon effects, says BMO Capital
BMO Capital says that fast food companies "are likely more insulated" from Amazon (AMZN) than other types of restaurants "due to their convenience-based usage occasions, low price points, and insulation from deflationary pressures." The firm identifies Wendy's (WEN) and McDonald's (MCD) as its favorite names in the fast food space.
09/11/17
WELS
09/11/17
NO CHANGE
WELS
Consumer survey shows most individuals shop on Amazon, says Wells Fargo
Wells Fargo analyst Ike Boruchow notes that ComScore online traffic data showed that 62% of all U.S. internet users visited Amazon.com during Q2, but the percentage of U.S. web users that visited Amazon declined 100bps. Nonetheless, the analyst says that per-visit and per-visitor metrics appear to be accelerating, meaning that even if the number of Amazon users is stabilizing, Amazon appears to be taking a greater share of time and wallet for each customer. His quarterly Amazon consumer survey shows that most individuals shop on Amazon, but that it still accounts for a somewhat small portion of total purchases. Lastly, Boruchow also argued that wholesalers seem to be generally aiming to take part in the web giant's growth, particularly as Amazon has made fashion/apparel more of a focus.
09/12/17
MSCO
09/12/17
NO CHANGE
MSCO
Augmented Reality the next 'killer app' to power Apple, says Morgan Stanley
A team of Morgan Stanley analysts including Katy Huberty, Brian Nowak and Grace Chen, among others, state in a new note to investors that they view Augmented Reality, or AR, as a revolutionary trend that can be "the next killer app" to extend the life of the smartphone market and accelerate device upgrades, led by Apple's (AAPL) iPhone. The analysts, who compare the impact of AR to the launch of Apple's App Store nearly a decade ago, add that they "don't expect the Android ecosystem to stand still in response." Huberty and the team raised the firm's "bull case" valuation of Apple, which they see taking the lead in AR, to $253 from $203. While they see Apple as "the clear leader" in AR, Google (GOOG) and Tencent (TCEHY) are also well-positioned and "interesting use cases" in e-commerce could benefit Alibaba (BABA) and Amazon (AMZN), they add.
09/12/17
LOOP
09/12/17
INITIATION
Target $1200
LOOP
Buy
Amazon.com initiated with a Buy at Loop Capital
Loop Capital analyst Anthony Chukumba started Amazon.com with a Buy rating and $1,200 price target, saying he sees the company's e-commerce and cloud computing platforms yielding "many years" of robust growth.

TODAY'S FREE FLY STORIES

WIT

Wipro

$5.61

-0.16 (-2.77%)

06:43
01/22/18
01/22
06:43
01/22/18
06:43
Downgrade
Wipro rating change  »

Wipro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.75

-2.25 (-3.75%)

06:41
01/22/18
01/22
06:41
01/22/18
06:41
Downgrade
CBS rating change  »

CBS downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

PANW

Palo Alto Networks

$157.22

-0.6 (-0.38%)

06:40
01/22/18
01/22
06:40
01/22/18
06:40
Downgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

DIS

Disney

$110.59

0.17 (0.15%)

06:40
01/22/18
01/22
06:40
01/22/18
06:40
Recommendations
Disney analyst commentary  »

Disney Q1 seen lower on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

PANW

Palo Alto Networks

$157.22

-0.6 (-0.38%)

06:40
01/22/18
01/22
06:40
01/22/18
06:40
Downgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

SPX

S&P 500

06:39
01/22/18
01/22
06:39
01/22/18
06:39
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$53.00

0.66 (1.26%)

06:38
01/22/18
01/22
06:38
01/22/18
06:38
Upgrade
Harley-Davidson rating change  »

Wells Fargo upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CRZO

Carrizo Oil & Gas

$22.62

-0.21 (-0.92%)

06:37
01/22/18
01/22
06:37
01/22/18
06:37
Hot Stocks
Carrizo Oil & Gas closes DJ Basin divestiture »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

AEP

American Electric

$67.76

-0.04 (-0.06%)

06:37
01/22/18
01/22
06:37
01/22/18
06:37
Upgrade
American Electric rating change  »

American Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

PEG

PSEG

$49.80

0.06 (0.12%)

06:37
01/22/18
01/22
06:37
01/22/18
06:37
Upgrade
PSEG rating change  »

PSEG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$23.65

0.04 (0.17%)

06:36
01/22/18
01/22
06:36
01/22/18
06:36
Technical Analysis
Market Vector Gold Miners: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$16.26

-0.51 (-3.04%)

06:35
01/22/18
01/22
06:35
01/22/18
06:35
Downgrade
General Electric rating change  »

General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

GLD

SPDR Gold Trust

$126.42

0.56 (0.44%)

06:35
01/22/18
01/22
06:35
01/22/18
06:35
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,137.51

7.72 (0.68%)

, GOOGL

Alphabet Class A

$1,143.50

7.53 (0.66%)

06:35
01/22/18
01/22
06:35
01/22/18
06:35
Periodicals
YouTube to form 'Intelligence Desk' to spot inappropriate content, BuzzFeed says »

Google's YouTube is…

GOOG

Alphabet

$1,137.51

7.72 (0.68%)

GOOGL

Alphabet Class A

$1,143.50

7.53 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

CELG

Celgene

$102.65

0.93 (0.91%)

, JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

06:34
01/22/18
01/22
06:34
01/22/18
06:34
Earnings
Celgene backs 2020 financial target of adj. EPS greater than $12.50 »

Backs 2020 financial…

CELG

Celgene

$102.65

0.93 (0.91%)

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

MTDR

Matador

$31.66

-0.53 (-1.65%)

, PAA

Plains All American

$22.49

-0.09 (-0.40%)

06:34
01/22/18
01/22
06:34
01/22/18
06:34
Hot Stocks
Matador enters strategic relationship with Plains All American in Rustler Breaks »

Matador (MTDR) announced…

MTDR

Matador

$31.66

-0.53 (-1.65%)

PAA

Plains All American

$22.49

-0.09 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 07

    Feb

  • 15

    May

NUGT

Direxion Gold Miners Bull

$32.84

0.05 (0.15%)

06:34
01/22/18
01/22
06:34
01/22/18
06:34
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDXC

ChromaDex

$5.85

0.41 (7.54%)

06:34
01/22/18
01/22
06:34
01/22/18
06:34
Hot Stocks
ChromaDex: PTAB denies Elysium Health's request to invalidate '807 patent »

ChromaDex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$131.85

-0.54 (-0.41%)

06:34
01/22/18
01/22
06:34
01/22/18
06:34
Downgrade
Visteon rating change  »

Visteon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$17.93

0.21 (1.19%)

06:33
01/22/18
01/22
06:33
01/22/18
06:33
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

, JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

06:33
01/22/18
01/22
06:33
01/22/18
06:33
Hot Stocks
Celgene to buy Juno Therapeutics for approximately $87 per share in cash »

Celgene Corporation…

CELG

Celgene

$102.65

0.93 (0.91%)

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

DUST

Direxion Daily Gold Miners Bear 3X ETF

$22.20

-0.1 (-0.45%)

06:32
01/22/18
01/22
06:32
01/22/18
06:32
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$71.94

-2.21 (-2.98%)

06:32
01/22/18
01/22
06:32
01/22/18
06:32
Downgrade
Adient rating change  »

Adient downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$49.12

-0.44 (-0.89%)

06:31
01/22/18
01/22
06:31
01/22/18
06:31
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

, JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

06:31
01/22/18
01/22
06:31
01/22/18
06:31
Hot Stocks
Breaking Hot Stocks news story on Celgene, Juno Therapeutics »

Celgene to buy Juno…

CELG

Celgene

$102.65

0.93 (0.91%)

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.